Cargando…
PIK3CA copy number aberration and activation of the PI3K-AKT-mTOR pathway in varied disease states of penile cancer
BACKGROUND: Therapeutic targeting of the PI3K-AKT-mTOR pathway may benefit patients with advanced penile squamous cell carcinoma (PSCC). OBJECTIVES: To determine the prevalence of PIK3CA copy number gain and correlate this with the activity status of PI3K-AKT-mTOR pathway in pre-malignant penile int...
Autores principales: | Adimonye, Anthony, Stankiewicz, Elzbieta, La-Touche, Susannah, Kudahetti, Sakunthala, Trevisan, Giorgia, Tinwell, Brendan, Corbishley, Cathy, Lu, Yong-Jie, Watkin, Nick, Berney, Daniel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6002057/ https://www.ncbi.nlm.nih.gov/pubmed/29902261 http://dx.doi.org/10.1371/journal.pone.0198905 |
Ejemplares similares
-
Analysis of the PI3K-AKT-mTOR pathway in penile cancer: evaluation of a therapeutically targetable pathway
por: Adimonye, Anthony, et al.
Publicado: (2018) -
DNA Copy Number Aberrations, and Human Papillomavirus Status in Penile Carcinoma. Clinico-Pathological Correlations and Potential Driver Genes
por: La-Touche, Susannah, et al.
Publicado: (2016) -
Alternative HER/PTEN/Akt Pathway Activation in HPV Positive and Negative Penile Carcinomas
por: Stankiewicz, Elzbieta, et al.
Publicado: (2011) -
Topical Therapy for non-invasive penile cancer (Tis)—updated results and toxicity
por: Manjunath, Aditya, et al.
Publicado: (2017) -
Dissection of PIK3CA Aberration for Cervical Adenocarcinoma Outcomes
por: Chung, Tony K. H., et al.
Publicado: (2021)